clinical_trials
Abdakibart Shows Strong Early Efficacy in Hidradenitis Suppurativa
Confidence86·multiple reportsImportance88NP-EVT-20261104-5434246
(MedPage Today) -- Phase II findings presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising early efficacy with abdakibart, an investigational interleukin (IL)-1 beta inhibitor, in patients with hidradenitis...
Read the original at the primary source
Abdakibart Shows Strong Early Efficacy in Hidradenitis Suppurativa
11/4/2026, 6:46:22 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —